Therapeutic strategies for Duchenne muscular dystrophy: an update

C Sun, L Shen, Z Zhang, X Xie - Genes, 2020 - mdpi.com
Neuromuscular disorders encompass a heterogeneous group of conditions that impair the
function of muscles, motor neurons, peripheral nerves, and neuromuscular junctions. Being …

Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells

FS Tedesco, A Dellavalle… - The Journal of …, 2010 - Am Soc Clin Investig
Skeletal muscle damaged by injury or by degenerative diseases such as muscular
dystrophy is able to regenerate new muscle fibers. Regeneration mainly depends upon …

[图书][B] Biomedical engineering handbook 2

JD Bronzino - 2000 - books.google.com
As we enter the new millennium, the prospects for the field of Biomedical Engineering are
bright. Individuals interested in pursuing careers in this field continue to increase and the …

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.

TA Rando, HM Blau - The Journal of cell biology, 1994 - rupress.org
The transplantation of cultured myoblasts into mature skeletal muscle is the basis for a new
therapeutic approach to muscle and non-muscle diseases: myoblast-mediated gene …

Stem and progenitor cells in skeletal muscle development, maintenance, and therapy

B Péault, M Rudnicki, Y Torrente, G Cossu… - Molecular therapy, 2007 - cell.com
Satellite cells are dormant progenitors located at the periphery of skeletal myofibers that can
be triggered to proliferate for both self-renewal and differentiation into myogenic cells. In …

Stem cell therapy for muscular dystrophies

S Biressi, A Filareto, TA Rando - The Journal of Clinical …, 2020 - Am Soc Clin Investig
Muscular dystrophies are a heterogeneous group of genetic diseases, characterized by
progressive degeneration of skeletal and cardiac muscle. Despite the intense investigation …

Myoblast transfer in the treatment of Duchenne's muscular dystrophy

JR Mendell, JT Kissel, AA Amato, W King… - … England Journal of …, 1995 - Mass Medical Soc
Background Myoblast transfer has been proposed as a technique to replace dystrophin, the
skeletal-muscle protein that is deficient in Duchenne's muscular dystrophy. Donor myoblasts …

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell–like properties as the myogenic source

JR Beauchamp, JE Morgan, CN Pagel… - The Journal of cell …, 1999 - rupress.org
Myoblasts, the precursors of skeletal muscle fibers, can be induced to withdraw from the cell
cycle and differentiate in vitro. Recent studies have also identified undifferentiated …

Stem cell-based therapies for Duchenne muscular dystrophy

C Sun, C Serra, G Lee, KR Wagner - Experimental neurology, 2020 - Elsevier
Muscular dystrophies are a group of genetic muscle disorders that cause progressive
muscle weakness and degeneration. Within this group, Duchenne muscular dystrophy …

Development of approaches to improve cell survival in myoblast transfer therapy

Z Qu, L Balkir, JCT Van Deutekom… - The Journal of cell …, 1998 - rupress.org
Myoblast transplantation has been extensively studied as a gene complementation
approach for genetic diseases such as Duchenne Muscular Dystrophy. This approach has …